Jim Bucher left the role of Executive Vice President and General Counsel at Eliem Therapeutics on February 14, 2023, according to an SEC filing.
| Name | Jim Bucher |
|---|---|
| Role | Executive Vice President and General Counsel |
| Company | Eliem Therapeutics |
| Industry | Biotechnology |
| Location | Redmond, WA |
| Move | Departure |
| Date | February 14, 2023 |
| Source | an SEC filing |
Eliem Therapeutics disclosed that Executive Vice President and General Counsel Jim Bucher would depart the company following a short transition period. (Source: an SEC filing.)
Other general counsel moves in February 2023
- Crystal Sumner Named Chief Legal Officer of Marqeta (February 28, 2023)
- Carlos M. Pelayo Named Chief Legal Officer of Mr. Cooper Group (February 28, 2023)
- Roger Seiken Named General Counsel of WideOpenWest (February 23, 2023)
- Laura Fese Steps Down as General Counsel and Corporate Secretary of E2open (February 22, 2023)
- Pam Swidler Named Chief Legal Officer, Chief Compliance Officer and Corporate Secretary of WeWork (February 21, 2023)
- Jared DeMatteis Steps Down as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary of WeWork (February 21, 2023)
- David Francis Steps Down as General Counsel of Maximus (February 21, 2023)
- Craig Martin Steps Down as General Counsel of WideOpenWest (February 21, 2023)
Planning your own next move?
Read our guide to becoming a general counsel and the in-house counsel salaries guide.
Browse every appointment in the General Counsel Directory.
Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.
Does this information need updating? Email us at info@inhouseblog.com.